Showing results (101-110 of 118) with videos related to
Sort By:
Pageof 12
Frontiers in Microbiology|December 14, 2023
Tumor Treating Fields (TTFields) demonstrate antiviral functions in vitro, and safety for application to COVID-19 patients in a pilot clinical studyAvraham Abutbul, Helena Mumblat, Yaara Porat, et al.Lung Cancer (Amsterdam, Netherlands)|September 5, 2021
Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical modelsHelena Mumblat, Antonia Martinez-Conde, Ori Braten, et al.Journal for Immunotherapy of Cancer|February 10, 2019
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancerAlexandros Papachristofilou, Madeleine M Hipp, Ute Klinkhardt, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 25, 2018
Pembrolizumab as Palliative Immunotherapy in Malignant Pleural MesotheliomaYannis Metaxas, Gareth Rivalland, Laetitia A Mauti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 12, 2021
SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II TrialSacha I Rothschild, Alfred Zippelius, Eric I Eboulet, et al.Cell Death Discovery|July 10, 2025
The transcriptomic fingerprint of cancer response to Tumor Treating Fields (TTFields)Kerem Wainer-Katsir, Adi Haber, Hila Fishman, et al.Cell Death & Disease|March 28, 2025
Role of the PI3K/AKT signaling pathway in the cellular response to Tumor Treating Fields (TTFields)Anat Klein-Goldberg, Tali Voloshin, Efrat Zemer Tov, et al.International Journal of Cancer|February 27, 2026
Efficacy and immunogenic effects of Tumor Treating Fields (TTFields) in preclinical models of pancreatic ductal adenocarcinoma, with and without gemcitabine/nab-paclitaxelTal Kan, Tharwat Haj Khalil, Yiftah Barsheshet, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 9, 2019
Evolution and Clinical Impact of EGFR Mutations in Circulating Free DNA in the BELIEF TrialMiguel-Angel Molina-Vila, Rolf A Stahel, Urania Dafni, et al.Nature Communications|September 30, 2025
Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapyDominic Schmid, Bettina Sobottka, Massimiliano Manzo, et al.Pageof 12